Table 4.
Inappropriate antibiotic Usage (n = 2022)
| Antibiotics | Inappropriate indication N (%) |
Inappropriate dosage N (%) |
Inappropriate treatment N (%) |
|---|---|---|---|
| Penicillins | 173 (61.1) | 140 (49.5) | 201 (71.0) |
| Narrow/broad spectrum | 81 (67.5) | 92 (76.7) | 102 (85.0) |
| With β-lactamase inhibitor | 92 (56.4) | 48 (29.5) | 99 (60.7) |
| Cephalosporins | 470 (50.4) | 418 (44.8) | 627 (67.2) |
| 1st generation | 37 (32.5) | 72 (86.7) | 92 (80.7) |
| 2nd generation | 32 (38.5) | 49 (59.1) | 66 (79.5) |
| 3rd generation | 395 (54.2) | 293 (40.2) | 463 (63.5) |
| 4th generation | 6 (85.7) | 4 (57.1) | 6 (85.7) |
| Carbapenems | 20 (76.6) | 18 (58.1) | 22 (70.9) |
| Macrolides | 37 (62.7) | 29 (49.2) | 44 (74.6) |
| Aminoglycosides | 67 (21.2) | 84 (26.6) | 113 (35.8) |
| Fluoroquinolones | 71 (36.8) | 108 (55.9) | 124 (64.2) |
| Others Antibacterial | 67 (32.2) | 133 (63.9) | 152 (73.1) |